perspectives 2017: Controlled transformation - the very prerequisite for corporate growth
Experts discuss digitalisation and growth factors for the pharmaceutical and chemical industries
What can the pharma-chemical industry do to assume a future-proof stance in the face of wide-ranging global change and increasing digitalisation? What are the decisive factors for securing sustainable growth? What types of business models are promising, and which ones are not? These and other related questions were discussed at the perspectives 2017, the top event for the pharmaceutical and chemical industries, which was hosted, for the fifth time, by Infraserv Höchst and attended by approximately 150 participants.
The strong consensus among all speakers: companies need to seize the opportunities now offered by the far-reaching transformation processes. To do this, they will have to demonstrate agility and flexibility – and better today than tomorrow.
The speakers: Minds, ideas, perspectives
Dr. Joachim von Heimburg
Innovation Architect and Managing Director
Prof. Dr. Gunter Dueck
Mathematician, author, philosopher, future thinker, satirist
Dr. Helmut Linde
Global Head of Data Science & Analytics Merck
Dr. Franz Josef Konert
CEO Gelita
Martin Haag
Plant manager Roche Diagnostics
Dr. Jürgen Stebani
Co-owner and CEO, Polymaterials AG